Endocrine Abstracts

After treatment, hyperthyroidism will relapse in approximately half of the Graves’ diseases patients, and clinically relevant orbitopathy will develop in about 25% of the diseased. Therefore, predicting who will relapse or develop orbitopathy is both clinically important and contributes to understanding of the pathophysiology of the disease. To predict the risk of recurrence of hyperthyroidism, before the start of antithyroid drug therapy, GREAT (based on clinical markers...